Skip to main content

Table 1 Characteristics of patients treated for CAF

From: Midterm follow up of transcatheter closure of coronary artery fistula with Nit-Occlud® patent ductus arteriosus coil

No

Age (years)

sex

Weight (kg)

Clinical presentationa

Associated CHD

Origin site

Drainage site

Device size PFM-coil

Type of closure

Anticoagulation

1

1.3

M

10

Heart murmur

No

LCS

RV cavity

7*6

Retrograde

ASA

2

2.1

F

9.4

Heart murmur

No

LCS

RV cavity

9*6

Retrograde

ASA

3

10 mo

M

6

Heart murmur

No

LCS

RV cavity

7*6

Retrograde

ASA

4

3.2

M

12.5

Tachycardia, hyperkinetic heart

No

LCS

RV cavity

7*6

Retrograde

ASA

5

1mo

M

3

Heart murmur

Dilated RSVC

RCS

RA

5*4

Retrograde

ASA

6

3.1

M

13

Heart murmur

No

RCS

RVOT

7*6 and 4*5

Antegrade

ASA

7

8 days

M

3.1

Heart failure

ASD

RCS

SVC

6*5

Retrograde

ASA

8

3.3

M

12.8

Perspiration, tachycardia

No

RCS

RV

7*6

Retrograde

ASA

9

7.2

F

17

Heart murmur, perspiration

No

RCS

RV

7*6

Retrograde

ASA

10

4 days

F

2.9

Heart failure

ASD

RCS

RA

9*6

Antegrade

ASA

11

3.5

M

13.2

Perspiration, tachycardia

NO

RCS

RV

7*6

Retrograde

ASA

12

15 days

F

2.8

Perspiration, tachycardia

No

LCS

RV

6*5

Antegrade

ASA, clopidogrel

  1. ASA aspirin, F female, LCS left coronary sinuous, LV left ventricle, M male, RCS right coronary sinuous, RV right ventricle, RVOT right ventricular outflow tract
  2. aEarly clinical presentation and cause of referral to cardiologist